Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 173 days ago

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 328 days ago

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 444 days ago

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 818 days ago

RBA Vigilant To Upside Risks To Inflation, Minutes Show

The Reserve Bank of Australia remained vigilant to upside risks to inflation and the board affirmed that the policy would need to be sufficiently restrictive until inflation moves sustainably towards the target, the minutes of the policy board meeting held on November 4 and 5 showed Tuesday.

RTTNews | 5h 28min ago

Antipodean Currencies Rise As Asian Markets Trade Mostly Higher

Antipodean currencies such as the Australian and the New Zealand dollars strengthened against their major currencies in the Asian session on Tuesday, as traders picked up some stocks at a bargain after the recent weakness in the markets amid concerns about the outlook for interest rates. Strong gains in mining and energy stocks also boosted the markets amid climbing commodity prices.

RTTNews | 5h 55min ago

Super Micro Stock Surges After Hiring New Auditor; Plans To Avoid Delisting

Shares of Super Micro Computer Inc. surged around 40 percent in the extended trading on The Nasdaq Stock Market after the troubled server maker announced that it has hired a new auditor and filed a compliance plan with the stock exchange, with a view to avoiding its delisting. The plan was submitted to support its request for an extension of time to regain compliance with the Nasdaq...

RTTNews | 6h 9min ago

NZ Dollar Advances Against Most Majors

The New Zealand dollar strengthened against most major currencies in the Asian session on Tuesday.

RTTNews | 6h 45min ago

EURUSD	1.05865	GBPUSD	1.26713	AUDUSD	0.65162
USDJPY	154.254	USDCAD	1.40058	USDCHF	0.8837